<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Almanac of Clinical Medicine</journal-id><journal-title-group><journal-title xml:lang="en">Almanac of Clinical Medicine</journal-title><trans-title-group xml:lang="ru"><trans-title>Альманах клинической медицины</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2072-0505</issn><issn publication-format="electronic">2587-9294</issn><publisher><publisher-name xml:lang="en">Moscow Regional Research and Clinical Institute (MONIKI)</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1230</article-id><article-id pub-id-type="doi">10.18786/2072-0505-2020-48-001</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>POINT OF VIEW</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ТОЧКА ЗРЕНИЯ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">To solve the problem of driving a car in epilepsy: by liberalization or by tightening the license?</article-title><trans-title-group xml:lang="ru"><trans-title>Решение проблемы вождения автомобильного транспорта при эпилепсии – путем либерализации или ужесточения допуска?</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6499-3054</contrib-id><name-alternatives><name xml:lang="en"><surname>Ponomareva</surname><given-names>I. V.</given-names></name><name xml:lang="ru"><surname>Пономарева</surname><given-names>И. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p><bold>Irina V. Ponomareva</bold> – MD, PhD, Head of Neurological Outpatient Department No. 2, Neurologist, Epileptologist.</p><p>287 Pobedy prospekt, Chelyabinsk, 454021</p></bio><bio xml:lang="ru"><p><bold>Пономарева Ирина Викторовна</bold> – канд. мед. наук, заведующая неврологическим отделением № 2 поликлиники № 2, врач-невролог, врач-эпилептолог.</p><p>454021, г. Челябинск, проспект Победы, 287</p></bio><email>irina_victorovna@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Gerzen</surname><given-names>A. P.</given-names></name><name xml:lang="ru"><surname>Герцен</surname><given-names>А. П.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p><bold>Anton P. Gerzen</bold> – MD, Head of the Regional Center for Diagnosis and Treatment of Epilepsy, Neurologist, Epileptologist.</p><p>202 Komsomol'skaya ul., Orenburg, 460035</p></bio><bio xml:lang="ru"><p><bold>Герцен Антон Петрович</bold> – заведующий областным центром диагностики и лечения эпилепсии, врач-невролог, врач-эпилептолог.</p><p>460035, г. Оренбург, ул. Комсомольская, 202</p></bio><email>antngercen@yandex.ru</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9910-3285</contrib-id><name-alternatives><name xml:lang="en"><surname>Lapina</surname><given-names>M. N.</given-names></name><name xml:lang="ru"><surname>Лапина</surname><given-names>М. Н.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p><bold>Marina N. Lapina</bold> – MD, Neurologist, Epileptologist, Neurological Center.</p><p>8 Verkhosunskaya ul., Kirov, 610007</p></bio><bio xml:lang="ru"><p><bold>Лапина Марина Николаевна</bold> – врач-невролог, врач-эпилептолог неврологического центра.</p><p>610007, г. Киров, ул. Верхосунская, 8</p></bio><email>pleasant79@mail.ru</email><xref ref-type="aff" rid="aff3"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5740-1022</contrib-id><name-alternatives><name xml:lang="en"><surname>Sherman</surname><given-names>M. A.</given-names></name><name xml:lang="ru"><surname>Шерман</surname><given-names>М. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p><bold>Mikhail A. Sherman</bold> – MD, PhD, Associate Professor, Head of the Department of Neurology and Neurosurgery.</p><p>112 Karla Marksa ul., Kirov, 610998Tel.: +7 (912) 826 06 05 </p></bio><bio xml:lang="ru"><p><bold>Шерман Михаил Айзикович</bold> – д-р мед. наук, доцент, заведующий кафедрой неврологии и нейрохирургии.</p><p>610998, г. Киров, ул. Карла Маркса, 112Тел.: +7 (912) 826 06 05 </p></bio><email>sherman@list.ru</email><xref ref-type="aff" rid="aff4"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Regional Clinical Hospital No. 3</institution></aff><aff><institution xml:lang="ru">ГБУЗ «Областная клиническая больница № 3»</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Orenburg Regional Clinical Psychoneurological Hospital for War Veterans</institution></aff><aff><institution xml:lang="ru">ГУЗ «Оренбургский областной клинический психоневрологический госпиталь ветеранов войн»</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">Center for Cardiology and Neurology</institution></aff><aff><institution xml:lang="ru">КОГБУЗ «Центр кардиологии и неврологии»</institution></aff></aff-alternatives><aff-alternatives id="aff4"><aff><institution xml:lang="en">Kirov State Medical University</institution></aff><aff><institution xml:lang="ru">ФГБОУ ВО «Кировский государственный медицинский университет» Минздрава России</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2020-03-17" publication-format="electronic"><day>17</day><month>03</month><year>2020</year></pub-date><volume>48</volume><issue>1</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>65</fpage><lpage>72</lpage><history><date date-type="received" iso-8601-date="2020-02-07"><day>07</day><month>02</month><year>2020</year></date><date date-type="accepted" iso-8601-date="2020-02-07"><day>07</day><month>02</month><year>2020</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2020, Ponomareva I.V., Gerzen A.P., Lapina M.N., Sherman M.A.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2020, Пономарева И.В., Герцен А.П., Лапина М.Н., Шерман М.А.</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="en">Ponomareva I.V., Gerzen A.P., Lapina M.N., Sherman M.A.</copyright-holder><copyright-holder xml:lang="ru">Пономарева И.В., Герцен А.П., Лапина М.Н., Шерман М.А.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://almclinmed.ru/jour/article/view/1230">https://almclinmed.ru/jour/article/view/1230</self-uri><abstract xml:lang="en"><p>In the modern mobile world, there is no single solution to the problem of issuing a driving license for patients with epilepsy. Most countries do have liberalized laws that allow driving a car to persons with controlled epilepsy. As far as individuals with regular seizures are concerned, there is a temporary prohibition to drive with potential restoration of the driving right if there is no relapse. The existing experience has shown that such strategy can lead not only to higher quality of life of the patients (more than 70% patients with epilepsy has the right to drive a car), but also to ensure the road safety. Even with this quite liberal approach, about 20% of the drivers with epilepsy do not have their epilepsy fully controlled. In the countries with absolute prohibition of the driving in epilepsy, such as the Russian Federation and China, there is no official statistics on the issue. Based on our practical experience, we concluded on a high (at least 35%) prevalence of drivers among patients with epilepsy; this cannot but increase the risk of road accidents, including fatal. Based on a clinical observation, we illustrate the failure of the mechanisms to prevent road accidents related to epilepsy that are currently in force in the Russian Federation. In our opinion, the problem under discussion does not have an exclusively medical solution. Taking into consideration the accumulated world experience, ensuring of the road safety requires that the state law regulations should be in effect that include a differentiated approached to issuing of permissions to drive a car for persons with epilepsy, from one side, and a serious legal treatment of persons with epilepsy who ignore their adequate therapy and become a cause for road accidents inflicting an injury, from the other.</p></abstract><trans-abstract xml:lang="ru"><p>В современном мобильном мире не существует единого решения проблемы допуска страдающих эпилепсией пациентов к управлению автомобильным транспортом. Большинство стран имеет законы либеральной направленности, разрешающие лицам с контролируемыми эпилептическими приступами (ЭП) водить автомобиль. В отношении людей с сохраняющимися припадками накладывается временный запрет на управление автомобилем с перспективой восстановления права вождения в случае отсутствия рецидивов приступов. Опыт показывает, что подобный подход позволяет не только повысить качество жизни больных (свыше 70% пациентов с эпилепсией имеют право на управление автомобилем), но и обеспечить должный уровень безопасности дорожного движения. Даже при таком достаточно мягком подходе у 20% участвующих в дорожном движении лиц с ЭП отсутствует полный контроль припадков. В странах с абсолютным запретом вождения автомобиля при эпилепсии, таких как Российская Федерация и Китай, отсутствует доступная официальная статистика, отражающая состояние проблемы. На основании своего практического опыта авторы сделали вывод о высокой – не менее 35% – распространенности водителей среди пациентов, имеющих ЭП, что не может не повышать риск дорожно-транспортных происшествий, в том числе с летальным исходом. На примере описания клинического наблюдения проиллюстрирована неэффективность действующих в Российской Федерации механизмов профилактики дорожных аварий, связанных с ЭП. По мнению авторов, обсуждаемая проблема не имеет исключительно медицинского решения. Учитывая накопившийся мировой опыт, для обеспечения безопасности на дорогах необходимо государственное законодательное регулирование, предполагающее, с одной стороны, дифференцированный подход в решении вопроса допуска лиц с ЭП к вождению, а с другой – серьезную правовую оценку действий игнорирующих адекватное лечение эпилепсии пациентов, ставших причиной аварий с нанесением вреда здоровью людей.</p></trans-abstract><kwd-group xml:lang="en"><kwd>epilepsy</kwd><kwd>road transport</kwd><kwd>epileptic seizures during driving a car</kwd><kwd>liberalization of the driving license</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>эпилепсия</kwd><kwd>автотранспорт</kwd><kwd>эпилептические припадки во время вождения автомобиля</kwd><kwd>либерализация допуска к вождению автомобиля</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Mac TL, Tran DS, Quet F, Odermatt P, Preux PM, Tan CT. Epidemiology, aetiology, and clinical management of epilepsy in Asia: a systematic review. Lancet Neurol. 2007;6(6):533–43. doi: 10.1016/S1474-4422(07)70127-8.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>GBD 2015 Neurological Disorders Collaborator Group. Global, regional, and national burden of neurological disorders during 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Neurol. 2017;16(11): 877–97. doi: 10.1016/S1474-4422(17)30299-5.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Cockerell OC, Eckle I, Goodridge DM, Sander JW, Shorvon SD. Epilepsy in a population of 6000 re-examined: secular trends in first attendance rates, prevalence, and prognosis. J Neurol Neurosurg Psychiatry. 1995;58(5):570–6. doi: 10.1136/jnnp.58.5.570.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>de Boer HM, Mula M, Sander JW. The global burden and stigma of epilepsy. Epilepsy Behav. 2008;12(4):540–6. doi: 10.1016/j.yebeh.2007.12.019.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Chisholm D; WHO-CHOICE. Cost-effectiveness of first-line antiepileptic drug treatments in the developing world: a population-level analysis. Epilepsia. 2005;46(5):751–9. doi: 10.1111/j.1528-1167.2005.52704.x.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Wang WZ, Wu JZ, Ma GY, Dai XY, Yang B, Wang TP, Yuan CL, Hong Z, Bell GS, Prilipko L, de Boer HM, Sander JW. Efficacy assessment of phenobarbital in epilepsy: a large community-based intervention trial in rural China. Lancet Neurol. 2006;5(1):46–52. doi: 10.1016/S1474-4422(05)70254-4.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Kleinman A, Wang WZ, Li SC, Cheng XM, Dai XY, Li KT, Kleinman J. The social course of epilepsy: chronic illness as social experience in interior China. Soc Sci Med. 1995;40(10):1319–30. doi: 10.1016/0277-9536(94)00254-q.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Arcot Jayagopal L, Samson KK, Taraschenko O. Driving with drug-resistant and controlled seizures from a patient's perspective: Assessment of attitudes and practices. Epilepsy Behav. 2018;81:101–6. doi: 10.1016/j.yebeh.2018.01.023.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Gilliam F, Kuzniecky R, Faught E, Black L, Carpenter G, Schrodt R. Patient-validated content of epilepsy-specific quality-of-life measurement. Epilepsia. 1997;38(2):233–6. doi: 10.1111/j.1528-1157.1997.tb01102.x.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Gilliam F, Kuzniecky R, Meador K, Martin R, Sawrie S, Viikinsalo M, Morawetz R, Faught E. Patient-oriented outcome assessment after temporal lobectomy for refractory epilepsy. Neurology. 1999;53(4):687–94. doi: 10.1212/wnl.53.4.687.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Jehi L, Tesar G, Obuchowski N, Novak E, Najm I. Quality of life in 1931 adult patients with epilepsy: seizures do not tell the whole story. Epilepsy Behav. 2011;22(4):723–7. doi: 10.1016/j.yebeh.2011.08.039.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Welty TE, Willis SL, Welty EA. Effect of limited transportation on medication adherence in patients with epilepsy. J Am Pharm Assoc (2003). 2010;50(6):698–703. doi: 10.1331/JAPhA.2010.09081.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Myers L, Lancman M, Laban-Grant O, Lancman M, Jones J. Socialization characteristics in persons with epilepsy. Epilepsy Behav. 2017;72:99–107. doi: 10.1016/j.yebeh.2017.04.036.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Holland P, Lane S, Whitehead M, Marson AG, Jacoby A. Labor market participation following onset of seizures and early epilepsy: Findings from a UK cohort. Epilepsia. 2009;50(5):1030–9. doi: 10.1111/j.1528-1167.2008.01819.x.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Gordon KE, Dooley JM, Brna PM. Epilepsy and activity – a population-based study. Epilepsia. 2010;51(11):2254–9. doi: 10.1111/j.15281167.2010.02709.x.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Imataka G, Arisue K. Epilepsy-related automobile accidents in Japan: legal changes about a precedent and penal regulations. Eur Rev Med Pharmacol Sci. 2016;20(3):491–7.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Devinsky O. Epilepsy: A Patient and Family Guide. 3 rd edition. Demos Health; 2007. 408 p.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Epilepsy Foundation. State Driving Laws Database. [Internet]. Available from: http://www.epilepsy.com/driving-laws.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Sheth SG, Krauss G, Krumholz A, Li G. Mortality in epilepsy: driving fatalities vs other causes of death in patients with epilepsy. Neurology. 2004;63(6):1002–7. doi: 10.1212/01.wnl.0000138590.00074.9a.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Canadian Council of Motor Transport Administrators. Determining Driver Fitness in Canada. September 2013 [Internet]. Available from: http://ccmta.ca/en/publications/resources-home/item/determing-driver-fitness-in-canada-september-2013.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Winston GP, Jaiser SR. Western driving regulations for unprovoked first seizures and epilepsy. Seizure. 2012;21(5):371–6. doi: 10.1016/j.seizure.2012.03.008.</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>McLachlan RS, Starreveld E, Lee MA. Impact of mandatory physician reporting on accident risk in epilepsy. Epilepsia. 2007;48(8):1500–5. doi: 10.1111/j.1528-1167.2007.01051.x.</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Ooi WW, Gutrecht JA. International regulations for automobile driving and epilepsy. J Travel Med. 2000;7(1):1–4. doi: 10.2310/7060.2000.00001.</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Austroads. Assessing Fitness to Drive [Internet]. Available from: http://www.austroads.com.au/drivers-vehicles/assessing-fitness-to-drive.</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Brasil. Codigo de Transito Brasileiro: Instituido pela Lei no. 9503 de 23 de Setembro de 1997 [Internet]. 1a ed. Brasilia: DENATRAN. 2008; 708. Available from: https://www.direitonet.com.br/guias-de-estudo/exibir/176/Codigo-de-Transito-Brasileiro-Lei-no-9503-97.</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Al Zaid EH. Prevalence of patients with epilepsy unfit to drive. J Family Community Med. 2019;26(1):51–6. doi: 10.4103/jfcm.JFCM_177_17.</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Bonnett LJ, Powell GA, Tudur Smith C, Marson AG. Risk of a seizure recurrence after a breakthrough seizure and the implications for driving: further analysis of the standard versus new antiepileptic drugs (SANAD) randomised controlled trial. BMJ Open. 2017;7(7):e015868. doi: 10.1136/bmjopen-2017-015868.</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Schmedding E; Belgian Working Group on Epilepsy and Driving. Epilepsy and driving in Belgium: proposals and justification. Acta Neurol Belg. 2004;104(2):68–79.</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>International Bureau for Epilepsy. Survey on driving regulations in Europe [Internet]. February 1, 2012. Available from: http://ibe-epilepsy.org.</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Epilepsy and Driving in Europe: A report of the Second European Working Group on Epilepsy and Driving, an advisory board to the Driving License Committee of the European Union [Internet]. Final report; 3 April 2005. Available from: https://ec.europa.eu/transport/road_safety/sites/roadsafety/files/pdf/behavior/epilepsy_and_driving_in_europe_final_report_v2_en.pdf.</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Kwon C, Liu M, Quan H, Thoo V, Wiebe S, Jetté N. Motor vehicle accidents, suicides, and assaults in epilepsy: a population-based study. Neurology. 2011;76(9):801–6. doi: 10.1212/WNL.0b013e31820e7b3b.</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>Norton R, Vander Hoorn S, Roberts I, Jackson R, MacMahon S. Migraine: a risk factor for motor vehicle driver injury? Accid Anal Prev. 1997;29(5):699–701. doi: 10.1016/s00014575(97)00018-3.</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>Pohlmann-Eden B, Hynick N, Legg K. First seizure while driving (FSWD) – an underestimated phenomenon? Can J Neurol Sci. 2013;40(4): 540–5. doi: 10.1017/s0317167100014633.</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>Inamasu J, Nakatsukasa M, Tomiyasu K. Seizures occurring while driving in patients with and without diagnosis of epilepsy: Frequency and association with automobile accidents. J Clin Neurosci. 2019;59:75–8. doi: 10.1016/j.jocn.2018.11.003.</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation>Naik PA, Fleming ME, Bhatia P, Harden CL. Do drivers with epilepsy have higher rates of motor vehicle accidents than those without epilepsy? Epilepsy Behav. 2015;47:111–4. doi: 10.1016/j.yebeh.2015.04.016.</mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation>Krauss GL, Ampaw L, Krumholz A. Individual state driving restrictions for people with epilepsy in the US. Neurology. 2001;57(10):1780–5. doi: 10.1212/wnl.57.10.1780.</mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation>Al Rajeh S, Awada A, Bademosi O, Ogunniyi A. The prevalence of epilepsy and other seizure disorders in an Arab population: a community-based study. Seizure. 2001;10(6):410–4. doi: 10.1053/seiz.2001.0602.</mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation>Sillanpää M, Shinnar S. Obtaining a driver's license and seizure relapse in patients with childhood-onset epilepsy. Neurology. 2005;64(4):680–6. doi: 10.1212/01.WNL.0000151957.80848.0E.</mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation>Elliott JO, Long L. Perceived risk, resources, and perceptions concerning driving and epilepsy: a patient perspective. Epilepsy Behav. 2008;13(2):381–6. doi: 10.1016/j.yebeh.2008.04.019.</mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation>Bautista RE, Wludyka P. Driving prevalence and factors associated with driving among patients with epilepsy. Epilepsy Behav. 2006;9(4): 625–31. doi: 10.1016/j.yebeh.2006.08.020.</mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation>Lings S. Increased driving accident frequency in Danish patients with epilepsy. Neurology. 2001;57(3):435–9. doi: 10.1212/wnl.57.3.435.</mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation>Krumholz A, Hopp J. Driving Restrictions for Patients with Seizures and Epilepsy [Internet]. UpToDate. Topic 2226, Version 13.0. Available from: http://www.uptodate.com/contents/drivingrestrictions-for-patients-with-seizures-and-epilepsy.</mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation>Drazkowski J. An overview of epilepsy and driving. Epilepsia. 2007;48 Suppl 9:10–2. doi: 10.1111/j.1528-1167.2007.01392.x.</mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation>Punia V, Farooque P, Chen W, Hirsch LJ, Berg AT; Multicenter Study of Epilepsy Surgery, Blumenfeld H. Epileptic auras and their role in driving safety in people with epilepsy. Epilepsia. 2015;56(11):e182–5. doi: 10.1111/epi.13189.</mixed-citation></ref><ref id="B45"><label>45.</label><mixed-citation>Brown JW, Lawn ND, Lee J, Dunne JW. When is it safe to return to driving following first-ever seizure? J Neurol Neurosurg Psychiatry. 2015;86(1):60–4. doi: 10.1136/jnnp-2013307529.</mixed-citation></ref><ref id="B46"><label>46.</label><mixed-citation>U.S. Department of Transportation's Federal Motor Carrier Safety Administration. Seizure Disorders and Commercial Motor Vehicle Drivers Safety: Expert Panel Recommendations. [Internet]. October 2007. Available from: https://www.fmcsa.dot.gov/sites/fmcsa.dot.gov/files/docs/Seizure-Disorders-MEP-Recommendations-v2-prot.pdf.</mixed-citation></ref><ref id="B47"><label>47.</label><mixed-citation>Smith SJ. EEG in the diagnosis, classification, and management of patients with epilepsy. J Neurol Neurosurg Psychiatry. 2005;76 Suppl 2(Suppl 2):ii2–7. doi: 10.1136/jnnp.2005.069245.</mixed-citation></ref><ref id="B48"><label>48.</label><mixed-citation>Salinsky MC, Wegener K, Sinnema F. Epilepsy, driving laws, and patient disclosure to physicians. Epilepsia. 1992;33(3):469–72. doi: 10.1111/j.1528-1157.1992.tb01693.x. PMID: 1592021.</mixed-citation></ref><ref id="B49"><label>49.</label><mixed-citation>Dalrymple J, Appleby J. Cross sectional study of reporting of epileptic seizures to general practitioners. BMJ. 2000;320(7227):94–7. doi: 10.1136/bmj.320.7227.94.</mixed-citation></ref><ref id="B50"><label>50.</label><mixed-citation>Berg AT, Vickrey BG, Sperling MR, Langfitt JT, Bazil CW, Shinnar S, Walczak TS, Pacia S, Spencer SS. Driving in adults with refractory localization-related epilepsy. Multi-Center Study of Epilepsy Surgery. Neurology. 2000;54(3): 625–30. doi: 10.1212/wnl.54.3.625.</mixed-citation></ref><ref id="B51"><label>51.</label><mixed-citation>Bacon D, Fisher RS, Morris JC, Rizzo M, Spanaki MV. American Academy of Neurology position statement on physician reporting of medical conditions that may affect driving competence. Neurology. 2007;68(15):1174–7. doi: 10.1212/01.wnl.0000259514.85579.e0.</mixed-citation></ref><ref id="B52"><label>52.</label><mixed-citation>Xu Y, Zhou Z, Shanthosh J, Hackett ML, Anderson CS, Glozier N, Somerville E. Who is driving and who is prone to have traffic accidents? A systematic review and meta-analysis among people with seizures. Epilepsy Behav. 2019;94:252–7. doi: 10.1016/j.yebeh.2019.03.032.</mixed-citation></ref><ref id="B53"><label>53.</label><mixed-citation>Chen J, Yan B, Lu H, Ren J, Zou X, Xiao F, Hong Z, Zhou D. Driving among patients with epilepsy in West China. Epilepsy Behav. 2014;33:1–6. doi: 10.1016/j.yebeh.2014.01.020.</mixed-citation></ref></ref-list></back></article>
